Stock ABUS ARBUTUS BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Delayed Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
3.16 USD +0.96% Intraday chart for Arbutus Biopharma Corporation +4.98% +26.40%
Jun. 06 Arbutus Biopharma Says Imdusiran Plus VTP-300 Therapy Lowers HBsAg Levels in Trial MT
Jun. 06 Arbutus Biopharma Corporation Announces New Preliminary End-Of- Treatment Data from the Phase 2A Clinical Trial CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arbutus Biopharma Corporation Announces Retirement of Chief Scientific Officer, Michael J. Sofia Effective December 31, 2024
CI
Arbutus Biopharma Posts Q3 Net Loss, Lower Revenue; CEO to Retire, 24% Research Staff Cut
MT
Arbutus Biopharma Corporation Announces CEO Changes
CI
Arbutus Biopharma Corporation Announces President Changes
CI
Arbutus Biopharma Corporation Announces the Appointment of Melissa V. Rewolinski to Its Board of Directors
CI
Arbutus Biopharma Promotes Dr. Karen Sims to Chief Medical Officer, Hires Christopher Naftzger as Chief Compliance Officer
MT
Arbutus Biopharma Corporation Appoints Two New Executives
CI
Arbutus Biopharma Corporation Announces Resignation of Tram Tran from the Board of Directors, Effective on February 26, 2023
CI
Eupraxia Pharmaceuticals Inc. Appoints Industry Veteran, Paul Brennan, As Chief Business Officer
MT
Arbutus Biopharma Corporation Appoints Mike Mcelhaugh as Chief Operating Officer, Effective as of November 1, 2022
CI
Arbutus Biopharma Corporation Announces Resignation of Gaston Picchio as Chief Development Officer
CI
Insider Sell: Arbutus Biopharma
MT
Arbutus Biopharma Corporation Appoints Tram Tran, M.D. to its Board of Directors
CI
Arbutus Biopharma Corporation Appoints Lisa M. Caperelli as Vice President, Investor Relations
CI
Arbutus Biopharma Corporation Appoints Eric Venker as Director
CI
Arbutus Biopharma Corporation Names Andrew Cheng to its Board of Directors
CI
Arbutus Biopharma Corporation Announces Management Changes
CI
Arbutus Biopharma Corporation Announces Executive Changes, Effective March 31, 2019
CI
Arbutus Biopharma Corporation Announces Board Changes
CI
Arbutus Biopharma Corporation Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABUS Stock
  4. News Arbutus Biopharma Corporation
  5. Insiders